B | SE B | β | 95% CI for B | ||
Lower bound | Upper bound | ||||
Step 1 | |||||
(Constant) | −0.860 | 0.270 | −1.395 | −0.325 | |
Age | 0.015 | 0.005 | 0.293* | 0.005 | 0.024 |
Channelopathy vs cardiomyopathy | 0.123 | 0.159 | 0.073 | −0.192 | 0.439 |
Step 2 | |||||
(Constant) | −2.730 | 0.509 | −3.738 | −1.721 | |
Age | 0.007 | 0.004 | 0.139 | −0.002 | 0.016 |
Channelopathy vs cardiomyopathy | 0.033 | 0.142 | 0.020 | −0.248 | 0.314 |
BMQ–necessity | 0.039 | 0.015 | 0.236* | 0.011 | 0.068 |
BMQ–concern | −0.014 | 0.017 | −0.070 | −0.047 | 0.019 |
MASES-R | 0.586 | 0.132 | 0.430† | 0.324 | 0.848 |
BIPQ-treatment control | −0.010 | 0.031 | −0.028 | −0.071 | 0.052 |
BIPQ-coherence | −0.008 | 0.031 | −0.272 | −0.070 | 0.053 |
*p<0.01, †p<0.001.
BIPQ, Brief Illness Perception Questionnaire; BMQ, Beliefs about Medicines Questionnaire; MASES-R, Medication Adherence Self-Efficacy Scale-Revised.